There’s really no evidence that there’s any performance enhancement from meldonium, said Don Catlin, a long-time anti-doping expert and the scientific director of the Banned Substances Control Group.
Those questions highlight a difficult position for WADA, With scant existing research, how does it know meldonium enhances performance? Does it need to ban a drug like meldonium before it understands its benefits and potential harms because it sees athletes using the drug? And if it’s not enhancing performance, why are a large number of seemingly healthy athletes taking a drug used to treat patients with heart problems?
Full text is available at USA Today.